1Cannistra SA. Cancer of the ovary. N Engl J Med, 2004, 351 : 2519-2529.
2Kayikcioglu F, Kose MF, Boran N, et al. Neoadjuvant chemotherapy or primary surgery in advanced epithelial ovarian carcinoma. Int J Gynecol Cancer, 2001, 11:466-470.
3Chan YM, Ng TY, Ngan HY, et al. Quality of life in women treated with neoadjuvant chemotherapy for advanced ovarian cancer: a prospective longitudinal study. Gynecol Oncol, 2003, 88:9-16.
4Kuhn W, Rutke S, Spathe K, et al. Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics stage Ⅲc ovarian carcinoma. Cancer, 2001,92:2585-2591.
5Steed H, Oza AM, Murphy J, et al. A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancer. Int J Gyneeol Cancer, 2006, 16:47-53.
6Bristow RE, Chi DS. Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer:a metaanalysis. Gynecol Oncol, 2006, 103 : 1070-1076.
